B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis.
Hasselbalch
Hans Carl
HC
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology*; D006111:Graves Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008212:Lymphocyte Depletion; D000069283:Rituximab; D013967:Thyroiditis, Autoimmune / Q000188:drug therapy* / Q000276:immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab